Suemy Melim Yamada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suemy Melim Yamada has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Pontillo
Universidade de São Paulo, Brazil
1 shared publication - Marcella Cipelli
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
1 shared publication - Mariela Vera Roa
Universidade de São Paulo
1 shared publication - Niels Olsen Saraiva Câmara
Federal University of São Paulo
1 shared publication - Pablo Shimaoka Chagas
Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil
1 shared publication - Pedro Henrique Imenez Silva
Erasmus MC
1 shared publication
Latest Publications
- Open Access
- 6 July 2026
- Published by Wolters Kluwer Health in Kidney360
Kidney Health in a Changing Climate
Climate change has reshaped global health in unprecedented ways, with CKD increasingly recognized as a major climate-sensitive condition. Kidney diseases affect an estimated 850 million people worldwide, and countries with the highest incidence are often facing rapid social and economic vulnerability alongside sustained rises in annual temperatures. A growing body of evidence has demonstrated that recurrent heat exposure, failures in heat dissipation, and associated environmental stressors markedly increase the risk of acute kidney injury and accelerate its progression to CKD. On the other hand, epidemiological indicators reinforce this relationship, showing approximately a 30% increase in kidney disease morbidity in regions exposed to high heat, as well as heat-associated CKD epidemics in Central America, Mexico, India, and Sri Lanka, even in the absence of traditional risk factors. These patterns suggested that chronic heat stress and repeated dehydration during manual labor may act as catalysts that unmask metabolic vulnerabilities or enhance susceptibility to nephrotoxic exposures. In this review, we integrated robust population-level data with mechanistic biological insights to explain how these climatic trends disproportionately affect vulnerable populations. We examined historical and contemporary temperature trajectories, identified countries with the greatest climatic and epidemiological burden, and presented key indicators such as incidence, mortality, and clinically relevant population metrics. At the molecular level, we connected these findings to heat-sensitive pathways involving dehydration, mitochondrial dysfunction, tubular injury, inflammation, renal hypoperfusion, and uric acid stone formation. Finally, we situated these processes within the ecological and evolutionary context of human thermoregulation, highlighting a growing adaptation lag between accelerating global warming and the limits of human physiological resilience. Thus, we argued that a comprehensive understanding of these multilevel interactions, from environmental conditions to cellular metabolism, is crucial for shaping effective prevention efforts, early diagnostic strategies, and evidence-based policies capable of mitigating the global rise of heat-associated kidney disease.
- 6 July 2026
- Published by Wolters Kluwer Health in Kidney360
Open AccessKidney Health in a Changing Climate
Climate change has reshaped global health in unprecedented ways, with CKD increasingly recognized as a major climate-sensitive condition. Kidney diseases affect an estimated 850 million people worldwide, and countries with the highest incidence are often facing rapid social and economic vulnerability alongside sustained rises in annual temperatures. A growing body of evidence has demonstrated that recurrent heat exposure, failures in heat dissipation, and associated environmental stressors markedly increase the risk of acute kidney injury and accelerate its progression to CKD. On the other hand, epidemiological indicators reinforce this relationship, showing approximately a 30% increase in kidney disease morbidity in regions exposed to high heat, as well as heat-associated CKD epidemics in Central America, Mexico, India, and Sri Lanka, even in the absence of traditional risk factors. These patterns suggested that chronic heat stress and repeated dehydration during manual labor may act as catalysts that unmask metabolic vulnerabilities or enhance susceptibility to nephrotoxic exposures. In this review, we integrated robust population-level data with mechanistic biological insights to explain how these climatic trends disproportionately affect vulnerable populations. We examined historical and contemporary temperature trajectories, identified countries with the greatest climatic and epidemiological burden, and presented key indicators such as incidence, mortality, and clinically relevant population metrics. At the molecular level, we connected these findings to heat-sensitive pathways involving dehydration, mitochondrial dysfunction, tubular injury, inflammation, renal hypoperfusion, and uric acid stone formation. Finally, we situated these processes within the ecological and evolutionary context of human thermoregulation, highlighting a growing adaptation lag between accelerating global warming and the limits of human physiological resilience. Thus, we argued that a comprehensive understanding of these multilevel interactions, from environmental conditions to cellular metabolism, is crucial for shaping effective prevention efforts, early diagnostic strategies, and evidence-based policies capable of mitigating the global rise of heat-associated kidney disease.
- Open Access
NLRP3 and NLRP1/CARD8 pathways differently contribute to pyroptosis of CD8+ T cells of ART-treated HIV patients
HIV-infected (HIV) patients exhibit immune dysregulation independently of antiretroviral therapy. The inflammasome, a cytosolic complex responsible for cleavage of the inflammatory cytokines IL -1β and IL -18 and pyroptosis, is highly activated in peripheral blood mononuclear cells of HIV patients, suggesting its involvement in leukocyte dysfunction. While monocytes, B cells, and CD4+ T cells have been studied, little is known about CD8+ T lymphocytes. Therefore, we proposed to characterize the inflammasome activation in these cells, both the NLRP3 and NLRP1/CARD8 pathways, which are partially described in T cells. CD8+ T lymphocytes from non-HIV healthy donors (HD) and HIV patients were analyzed ex vivo and stimulated in vitro with known activators of NLRP3 (α-CD3/α-CD28), NLRP1 and CARD8 (DPP9 inhibitor ValboroPro, VbP) to assess inflammasome activation. HIV CD8+ T cells present a constitutively activated caspase-1 which positively correlates with the cell activation state. HIV CD8+ T cells were more activated and more resistant to VbP-induced pyroptosis than HD. On the other way, HIV CD8+ T lymphocytes showed higher pyroptosis in response to α-CD3/α-CD28. These findings suggest that the NLRP3 pathway is significantly dysregulated in those patients, and TCR stimulation may result in cell loss. At the same time, being HIV CD8+ T cells constitutively activated, other inflammasome pathways, such as NLRP1 or CARD8, present a delayed activation.
Open AccessNLRP3 and NLRP1/CARD8 pathways differently contribute to pyroptosis of CD8+ T cells of ART-treated HIV patients
HIV-infected (HIV) patients exhibit immune dysregulation independently of antiretroviral therapy. The inflammasome, a cytosolic complex responsible for cleavage of the inflammatory cytokines IL -1β and IL -18 and pyroptosis, is highly activated in peripheral blood mononuclear cells of HIV patients, suggesting its involvement in leukocyte dysfunction. While monocytes, B cells, and CD4+ T cells have been studied, little is known about CD8+ T lymphocytes. Therefore, we proposed to characterize the inflammasome activation in these cells, both the NLRP3 and NLRP1/CARD8 pathways, which are partially described in T cells. CD8+ T lymphocytes from non-HIV healthy donors (HD) and HIV patients were analyzed ex vivo and stimulated in vitro with known activators of NLRP3 (α-CD3/α-CD28), NLRP1 and CARD8 (DPP9 inhibitor ValboroPro, VbP) to assess inflammasome activation. HIV CD8+ T cells present a constitutively activated caspase-1 which positively correlates with the cell activation state. HIV CD8+ T cells were more activated and more resistant to VbP-induced pyroptosis than HD. On the other way, HIV CD8+ T lymphocytes showed higher pyroptosis in response to α-CD3/α-CD28. These findings suggest that the NLRP3 pathway is significantly dysregulated in those patients, and TCR stimulation may result in cell loss. At the same time, being HIV CD8+ T cells constitutively activated, other inflammasome pathways, such as NLRP1 or CARD8, present a delayed activation.